We are live on ! Find out more
AVNS

Avanos Medical
AVNS

Delisted

AVNS was delisted on the 24th of July, 2026.

468 hedge funds and large institutions have $1.6B invested in Avanos Medical in 2014 Q4 according to their latest regulatory filings, with 468 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

18% less call options, than puts

Call options by funds: $7.47M | Put options by funds: $9.08M

Holders
468
Holders Change
+468
Holders Change %
% of All Funds
12.48%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
468
Increased
Reduced
Closed
Calls
$7.47M
Puts
$9.08M
Net Calls
-$1.61M
Net Calls Change
-$1.61M

AVNS Hedge Fund Activity: Q4 2014 in Review

468 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2014, worth a combined $1.6B.

Buyers outnumbered sellers: 468 funds opened new AVNS positions and 0 closed out — a net gain of 468 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $125M.

  • 468 institutional investors held Avanos Medical (AVNS) as of Q4 2014, up from 0 in Q3 2014.
  • Funds reported $1.6B of Avanos Medical stock for Q4 2014.
  • 468 funds opened new Avanos Medical positions in Q4 2014 and 0 closed out, a net change of +468 holders.
  • The largest Avanos Medical buyer in Q4 2014 was T. Rowe Price Associates, an estimated $125M added.

Based on aggregated 13F filings for Q4 2014.